feed,title,long_url,short_url
Benzinga,Alnylam's Stock Gains Following FDA Nod For hATTR Amyloidosis Candidate,https://benzinga.com/general/biotech/22/06/27689160/alnylams-stock-gains-following-fda-nod-for-hattr-amyloidosis-candidate,https://bit.ly/3xuCdy9
